Prostate-specific antigen in the early detection of prostate cancer.
about
Positron emission tomography imaging of prostate cancerPopulation screening for prostate cancer: an overview of available studies and meta-analysisBiosensors: the new wave in cancer diagnosis.Keratin 8 expression in head and neck epithelia.A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressivenessGalectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice.A population study of fasting time and serum prostate-specific antigen (PSA) level.Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review.Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformaticsAbdominal and back pain in a 65-year-old patient with metastatic prostate cancerFunctions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.Genomic and proteomic biomarkers for cancer: a multitude of opportunities.Prostate-specific antigen-based screening for prostate cancer in the third millennium: useful or hype?Expressed prostatic secretion biomarkers improve stratification of NCCN active surveillance candidates: performance of secretion capacity and TMPRSS2:ERG models.Uptake of prostate cancer screening and associated factors among Chinese men aged 50 or more: a population-based survey.The implementation of screening for prostate cancer.Risk stratification in prostate cancer screening.Prostate adenocarcinoma associated with prostatic infection due to Schistosoma haematobium. Case report and systematic review.Protein microarrays as an application for disease biomarkers.Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence.Trends in the incidence of cancer in the Sousse region, Tunisia, 1993-2006.Cost-effectiveness of Prostate Health Index for prostate cancer detection.A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells.Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.Budget impact analysis of a new prostate cancer risk index for prostate cancer detection.Quadriplex model enhances urine-based detection of prostate cancer.Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml
P2860
Q24596241-31A53B73-06A8-4D45-9047-C6B37477C504Q26829319-8B800D4B-B67C-4BE7-9993-3420D833E280Q30447534-6FA27252-8B01-4BAD-BF64-9A026C01E6A4Q33370722-C084D9DB-9BD6-4D10-9432-340CAA0B51C6Q33839248-2B4892B7-7B41-4C06-AA97-2045151F11B0Q34058682-8BA662FE-7367-4B89-A772-61205DE12200Q34294898-E8489239-CCFE-4F2C-AFB2-3730B8AB6EF7Q34433274-4E911293-9695-465C-B0B9-1189893D1E8DQ34439388-7D907C33-3D8F-4EFC-9889-9FF0B8B83568Q34477513-878D10B6-0B1D-4CD1-8622-3E4668E705F0Q34840259-D43DE671-05A5-45CA-8711-B9FBD0BABA97Q36860976-E13195F6-AA83-4D16-8C7D-1722995B6D62Q37363928-EC03DFDD-3DA4-4CFD-A140-CFA3B871C567Q37573519-82DF7438-81A9-415A-9F5D-7E4ECE1BBB72Q37606770-2D8BE848-E44F-431B-A42F-18EE70092924Q37672443-5124FEA9-3C24-4F38-862D-C5904D8B3AF3Q37777325-6781D47A-742E-45C6-A0B2-85251D891203Q38068114-BFCD223C-8444-4A29-99DB-5E1999781D2BQ38302040-363DAFB6-5BA3-4F51-ACCC-D5D159E01449Q38559982-C99A8661-D8E3-4122-894F-0085D464F48DQ38838580-B30A25C0-A2BE-4886-9805-ABF5230507A1Q39254532-40B20DFE-DB15-4210-85DC-4DB2C413A274Q40007049-BCBBC2A8-0CDE-4519-BE53-13CC08A2266BQ43252751-DD81CBAE-5F9E-49B5-B9DA-B8545E4E81E4Q45810338-74E6EE70-9DC4-44FD-BA71-92469DA53188Q46098777-29112AF3-2EF8-4DA2-9F0C-39552A972E68Q50618165-75B4F172-6525-43EB-8203-358D8D299CE1Q57999041-F1DE8A53-7878-4AFD-BBD8-19BB2885ECBF
P2860
Prostate-specific antigen in the early detection of prostate cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Prostate-specific antigen in the early detection of prostate cancer.
@ast
Prostate-specific antigen in the early detection of prostate cancer.
@en
type
label
Prostate-specific antigen in the early detection of prostate cancer.
@ast
Prostate-specific antigen in the early detection of prostate cancer.
@en
prefLabel
Prostate-specific antigen in the early detection of prostate cancer.
@ast
Prostate-specific antigen in the early detection of prostate cancer.
@en
P2860
P356
P1476
Prostate-specific antigen in the early detection of prostate cancer.
@en
P2093
Ian M Thompson
P2860
P304
P356
10.1503/CMAJ.060955
P407
P577
2007-06-01T00:00:00Z